Business Daily.
.
A+ R A-

imagePARSIPPANY, N.J., Sept. 12, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today announced that it has launched Oxymorphone Hydrochloride Extended-release Tablets, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg.  Actavis' ANDA product is the generic equivalent to the previously marketed......


Page 1769 of 1908

Grow Your Business with Times Media
Business Daily Media